In Depth 7 Feb 2024
The biggest private biotech investments in January 2024
Jixing Pharmaceuticals, COUR Pharmaceuticals, and OnCusp Therapeutics bagged the biggest private biotech investments in January 2024.
Funding
- Latest Posts
Best in Biotech 29 Jan 2024
10 biotech accelerators shaping tomorrow’s innovations
Here are 10 biotech accelerators that are dedicated to fueling entrepreneurial goals of setting up successful life science companies.
News and Trends 18 Jan 2024
2024 J.P. Morgan Healthcare Conference: key takeaways from the largest biotech gathering of the year
Here are some of the key takeaways from the JPM Healthcare Conference that lay the groundwork for what we can expect in 2024.
Best in Biotech 11 Jan 2024
Ten NK cell therapy companies to look out for this year
As biotechs raise funding to advance their NK cell therapy candidates in the clinic, here are ten companies in the space to watch out for.
In Depth 10 Jan 2024
The biggest private biotech investments in December 2023
The companies Tome Biosciences, Bicara Therapeutics, and Seismic Therapeutic bagged the biggest biotech investments in December 2023. Around the world, food, immunology, oncology, central nervous system (CNS), and biofermentation players attracted the biggest funding rounds overall. Although December is generally a quiet time for biotech fundraising, there were still some big rounds raised in the […]
In Depth 7 Dec 2023
The biggest private biotech investments in November 2023
The companies Cambrian Innovation, Terremoto Biosciences, and VectorY Therapeutics bagged the biggest biotech investments in November 2023. Around the world, oncology and central nervous system players attracted the biggest funding rounds. As we edge closer to Christmas, biotech fundraising appears to be drying up a bit; there was a significant decrease in funding rounds in […]
ADVERTISEMENT
ADVERTISEMENT
News and Trends 17 Nov 2023
With $700 million Q3 rise, U.K. biotech spearheads European recovery
The U.K.’s biotechnology landscape has witnessed an impressive surge in funding, clocking a robust £563 million ($700 million) in venture capital and public financings in the third quarter of 2023, according to Biotech Finance. This achievement marks a staggering 48% increase from the previous quarter and sets a formidable pace that is already on track […]
In Depth 16 Nov 2023
Meet the ‘biotech mafia’: how specialized biotech VC firms are dominating industry funding once again
Between 2020 and 2022 – largely due to the biotech innovations that came about by the COVID-19 pandemic – there was an influx of generalist investors in the biotech industry, betting big on new technologies like mRNA vaccines. But, now, these investors appear to have backed off, leaving room for specialized biotech venture capital (VC) […]
In Depth 15 Nov 2023
Beyond oil and gas: Biotech’s significant place in the Qatar Investment Authority’s strategy
Since 2020, the Qatar Investment Authority (QIA) has been taking part in important biotech fundings reaching its peak in 2021 and remaining strong in 2023. They recently led a $250 million round in the company BridgeBio specialized in transformative medicine for patients suffering from cancer or genetic diseases. This investment is not an isolated case […]
Weekly Roundup 10 Nov 2023
Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs
You are reading Labiotech’s weekly roundup of the latest biotech news. Korro Bio and Frequency Therapeutics close merger Last Friday, Korro Bio announced the completion of the previously announced business combination between Frequency Therapeutics, Inc. and the entity formerly known as Korro Bio. The combined company will now operate under the name Korro Bio, Inc. […]
In Depth 6 Nov 2023
The biggest private biotech investments in October 2023
The companies Aiolos Bio, MapLight Therapeutics and Agomab Therapeutics bagged the biggest biotech investments in October 2023. Around the world, biomaterials, central nervous system and musculoskeletal disorder players attracted the most investor interest. October 2023 saw a lot of fundraising taking place both in and out of healthcare in the U.S. and Europe. However, the […]
In Depth 16 Oct 2023
Blockchain-based biotech: is this a viable financing method?
At a time when biotechs are scrambling to raise funds, a new way for startups to secure investments is emerging: leveraging cryptocurrency. The motive behind decentralized financing seems pretty ambitious – to democratize funding in healthcare. But does it live up to the hype? With VitaDAO – a decentralized collective that funds early-stage startups looking […]
ADVERTISEMENT
